News & Events

ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

A New Horizon

1 May 2019

A PharmaTimes article featuring commentary from Tom O’Leary on the future of AI in healthcare. O’Leary discusses how the key to maximising AI’s involvement in pharma development is to utilise its ability to draw distinctions and correlations, which would otherwise elude human observation. However, also notes the potential for AI is most exciting when paired with human experience, creativity and instinct.